Despite the few data regarding CALML3, it was reported that metformin suppresses gastric cancer through stimulating CALML3 secretion from gastric tumor--associated fibroblasts, representing a novel anti-cancer mechanism of metformin, and a tumor-suppressive role of CALML3 [35]. The gene discussed is CALML3; the disease is gastric neoplasm.